Reply to IL-18 is not therapeutic for neovascular age-related macular degeneration

Nature Medicine

Volumn 20, Issue 12, 2014, Pages 1376-1377

  Doyle, Sarah L ^a   Adamson, Peter ^b   López, Francisco J ^c   Humphries, Peter ^d   Campbell, Matthew ^d  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b GLAXOSMITHKLINE   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

^d TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IBOCTADEKIN; INTERLEUKIN 18; SUCROSE;

ADAPTIVE IMMUNITY; AGE RELATED MACULAR DEGENERATION; BIOLOGICAL ACTIVITY; CELL DEATH; CELL MATURATION; CELL VIABILITY; CYTOTOXICITY; FEVER; FOLLOW UP; HUMAN; IN VITRO STUDY; LETTER; MICROBIOME; NATURAL KILLER CELL; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PIGMENT EPITHELIUM; PRIMARY CULTURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; VISION; ANIMAL; CHOROIDAL NEOVASCULARIZATION; MACULAR DEGENERATION;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; HUMANS; INTERLEUKIN-18; MACULAR DEGENERATION;

EID: 84923562143     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3741     Document Type: Letter

References (10)

1. Hirano, Y. et al. Nat. Med. 20, 1372-1375 (2014).
2. Doyle, S. L. et al. Sci. Transl. Med. 6, 230ra44 (2014).
3. Kleinman, M. E. et al. Nature 452, 591-597 (2008).
4. Rankin, E. B. et al. Cancer Biol. Ther. 2, 687-693 (2003).
5. Doyle, S. L. et al. Nat. Med. 18, 791-799 (2012).
6. Robertson, M. J. et al. Clin. Cancer Res. 14, 3462-3469 (2008).
7. Qiao, H. et al. J. Leukoc. Biol. 81, 1012-1021 (2007).
8. Herzyk, D. J., Bugelski, P. J., Hart, T. K., Wier, P. J. Toxicol. Pathol. 31, 554-561 (2003).
9. Shen, J. et al. J. Cell. Physiol. 229, 974-983 (2014).
10. Marneros, A. G. Cell Rep. 4, 945-958 (2013).